← SynDRA
AMG-208
SynDRA canonical compound SYN0016083 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | MET |
| Mechanism of action | Tyrosine kinase inhibitor |
All known targets
Mechanisms of action (all sources)
- tyrosine kinase inhibitor
- MET INHIBITOR
- Hepatocyte growth factor receptor inhibitor
- MET MODULATOR
Cross-references
Synonyms
- Amg208
- AMG208
- UNII-Y2SR66P7VM
- 7-methoxy-4-((6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methoxy)quinoline
- Y2SR66P7VM
- CHEBI:90626
- 7-methoxy-4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methoxy]quinoline
- 7-Methoxy-4-[(6-phenyl-1,2,4-triazolo[4,3-b]pyridazin-3-yl)methoxy]quinoline
- C22H17N5O2
- 7-methoxy-4-[(6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methoxy]quinoline
- 7-methoxy-4-({6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl}methoxy)quinoline
- Triazolopyridazine, 4
- 3cd8
- AMG 208 [WHO-DD]
- RefChem:556946
- DTXCID3065530
- C-MET INHIBITOR AMG 208
- orb1300928
- SCHEMBL9910136
- SCHEMBL30274835
- BDBM24470
- GLXC-90535
- AMG-208?
- EX-A4656
- NSC766288
- NSC801016
- s1316
- AKOS015852294
- CS-0185
- NSC-766288
- NSC-801016
- SB16605
- SDCCGSBI-0654444.P001
- NCGC00346507-01
- NCGC00346507-07
- NCGC00346507-10
- AC-26862
- BS-14142
Look up AMG-208 in the interactive SynDRA portal →